![](/wp-content/uploads/2022/01/Other-Research-Resources-440x300-1.png")
Latest News
March 6, 2025
March 5, 2025
Posts
;
⬇️Enrolling PI: Jeremy D. Rudnick, MD
Great work to @CSCancerCenter for enrolling two patients in our #Glioblastoma study, EAF223/GABLE! This trial is testing different imaging techniques that could help make better predictions about #BrainCancer progression. Learn more here: https://bit.ly/gable-trial
.@michael_lidsky of @DukeSurgOnc and @DukeCancer is leading EA2222/PUMP, a randomized phase 3 study for patients with #Colorectal liver metastases. Learn more: https://bit.ly/ea2222-pump cc: @CCAlliance, @FightCRC, @NCCRTnews
Great work to @CSCancerCenter for enrolling two patients in our #Glioblastoma study, EAF223/GABLE! This trial is testing different imaging techniques that could help make better predictions about #BrainCancer progression. Learn more here: https://bit.ly/gable-trial
About Us
The ECOG-ACRIN Cancer Research Group is a strong network of nearly 1300 academic and community-based cancer centers and hospitals in the United States and around the world. We design and conduct biomarker-driven research involving adults who have or are at risk of developing cancer. Learn More
Scientific Pursuits
We are dedicated to improving life for adults affected by cancer. Through our member sites, we are pursuing a robust clinical and translational research portfolio that focuses on precision oncology, immunotherapy, reducing over-treatment and over-diagnosis, leveraging novel biomarker platforms to inform therapeutic decision-making, and advancing standards of care in broad populations of cancer patients and those at risk. Learn More
ECOG-ACRIN by the Numbers
41
Active Clinical Trials
1400
Participating Institutions
67
International Sites
21000
Individual Members
Scientifically rigorous, broadly multidisciplinary, organizationally robust, and internationally respected, the Group is a vibrant component of the National Cancer Institute (NCI) National Clinical Trials Network (NCTN). In addition, we are a Research Base in the NCI Community Oncology Research Program (NCORP).
